TCT-280 BIOFLOW-VI: BIOTRONIK—Safety and Clinical PerFormance of the Drug ELuting Orsiro Stent in the Treatment of Subjects With de novo Coronary Artery Lesions—VI: 2 Years Clinical Results

2019 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []